Israel Corp (ILCO) - Net Assets

Latest as of September 2025: ILA6.84 Billion ILA ≈ $18.34 Million USD

Based on the latest financial reports, Israel Corp (ILCO) has net assets worth ILA6.84 Billion ILA (≈ $18.34 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA13.40 Billion ≈ $35.94 Million USD) and total liabilities (ILA6.57 Billion ≈ $17.60 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Israel Corp liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets ILA6.84 Billion
% of Total Assets 51.02%
Annual Growth Rate 1.89%
5-Year Change 69.53%
10-Year Change 134.42%
Growth Volatility 87.64

Israel Corp - Net Assets Trend (2000–2024)

This chart illustrates how Israel Corp's net assets have evolved over time, based on quarterly financial data. Also explore ILCO total assets for the complete picture of this company's asset base.

Annual Net Assets for Israel Corp (2000–2024)

The table below shows the annual net assets of Israel Corp from 2000 to 2024. For live valuation and market cap data, see how much is Israel Corp worth.

Year Net Assets Change
2024-12-31 ILA6.38 Billion
≈ $17.11 Million
+0.25%
2023-12-31 ILA6.37 Billion
≈ $17.06 Million
+8.77%
2022-12-31 ILA5.85 Billion
≈ $15.69 Million
+36.57%
2021-12-31 ILA4.29 Billion
≈ $11.49 Million
+13.84%
2020-12-31 ILA3.76 Billion
≈ $10.09 Million
-3.06%
2019-12-31 ILA3.88 Billion
≈ $10.41 Million
+7.56%
2018-12-31 ILA3.61 Billion
≈ $9.68 Million
+36.90%
2017-12-31 ILA2.64 Billion
≈ $7.07 Million
+16.63%
2016-12-31 ILA2.26 Billion
≈ $6.06 Million
-16.94%
2015-12-31 ILA2.72 Billion
≈ $7.30 Million
-25.12%
2014-12-31 ILA3.63 Billion
≈ $9.75 Million
-2.15%
2013-12-31 ILA3.71 Billion
≈ $9.96 Million
-10.78%
2012-12-31 ILA4.16 Billion
≈ $11.16 Million
-0.05%
2011-12-31 ILA4.17 Billion
≈ $11.17 Million
+8.63%
2010-12-31 ILA3.83 Billion
≈ $10.28 Million
+15.34%
2009-12-31 ILA3.33 Billion
≈ $8.91 Million
-9.05%
2008-12-31 ILA3.66 Billion
≈ $9.80 Million
-67.84%
2007-12-31 ILA11.37 Billion
≈ $30.47 Million
+418.33%
2006-12-31 ILA2.19 Billion
≈ $5.88 Million
+13.59%
2005-12-31 ILA1.93 Billion
≈ $5.18 Million
-68.55%
2004-12-31 ILA6.14 Billion
≈ $16.46 Million
+50.32%
2003-12-31 ILA4.08 Billion
≈ $10.95 Million
+4.45%
2002-12-31 ILA3.91 Billion
≈ $10.48 Million
+2.41%
2001-12-31 ILA3.82 Billion
≈ $10.24 Million
-6.12%
2000-12-31 ILA4.07 Billion
≈ $10.90 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Israel Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 133.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings ILA2.60 Billion 92.44%
Common Stock ILA326.00 Million 11.58%
Other Comprehensive Income ILA-140.00 Million -4.97%
Other Components ILA27.00 Million 0.96%
Total Equity ILA2.82 Billion 100.00%

Israel Corp Competitors by Market Cap

The table below lists competitors of Israel Corp ranked by their market capitalization.

Company Market Cap
Central Garden & Pet Company A
NASDAQ:CENTA
$1.71 Billion
Camel Group Co Ltd
SHG:601311
$1.71 Billion
Shanghai Weaver Network Co Ltd
SHG:603039
$1.71 Billion
Peugeot Invest SA
PA:PEUG
$1.71 Billion
Jinlongyu Group Co Ltd Class A
SHE:002882
$1.71 Billion
Magnite Inc
NASDAQ:MGNI
$1.71 Billion
BASF India Limited
NSE:BASF
$1.70 Billion
Nurix Therapeutics Inc
NASDAQ:NRIX
$1.70 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Israel Corp's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,776,000,000 to 2,816,000,000, a change of 40,000,000 (1.4%).
  • Net income of 190,000,000 contributed positively to equity growth.
  • Dividend payments of 37,000,000 reduced retained earnings.
  • Share repurchases of 20,000,000 reduced equity.
  • Other comprehensive income decreased equity by 140,000,000.
  • Other factors increased equity by 47,000,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ILA190.00 Million +6.75%
Dividends Paid ILA37.00 Million -1.31%
Share Repurchases ILA20.00 Million -0.71%
Other Comprehensive Income ILA-140.00 Million -4.97%
Other Changes ILA47.00 Million +1.67%
Total Change ILA- 1.44%

Book Value vs Market Value Analysis

This analysis compares Israel Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 224.18x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 168.98x to 224.18x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-12-31 ILA497.52 ILA84070.00 x
2005-12-31 ILA160.49 ILA84070.00 x
2006-12-31 ILA176.04 ILA84070.00 x
2007-12-31 ILA754.82 ILA84070.00 x
2008-12-31 ILA213.55 ILA84070.00 x
2009-12-31 ILA237.70 ILA84070.00 x
2010-12-31 ILA312.98 ILA84070.00 x
2011-12-31 ILA323.02 ILA84070.00 x
2012-12-31 ILA296.88 ILA84070.00 x
2013-12-31 ILA220.95 ILA84070.00 x
2014-12-31 ILA240.36 ILA84070.00 x
2015-12-31 ILA126.02 ILA84070.00 x
2016-12-31 ILA105.43 ILA84070.00 x
2017-12-31 ILA132.84 ILA84070.00 x
2018-12-31 ILA182.66 ILA84070.00 x
2019-12-31 ILA203.25 ILA84070.00 x
2020-12-31 ILA183.98 ILA84070.00 x
2021-12-31 ILA201.60 ILA84070.00 x
2022-12-31 ILA321.97 ILA84070.00 x
2023-12-31 ILA363.92 ILA84070.00 x
2024-12-31 ILA375.02 ILA84070.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Israel Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 6.75%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 2.78%
  • • Asset Turnover: 0.55x
  • • Equity Multiplier: 4.44x
  • Recent ROE (6.75%) is below the historical average (10.07%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2000 6.18% 1.16% 0.63x 8.51x ILA-79.93 Million
2003 14.98% 3.18% 0.65x 7.29x ILA108.00 Million
2004 8.83% 5.82% 0.25x 6.11x ILA-42.38 Million
2005 29.36% 5.95% 1.03x 4.80x ILA227.22 Million
2006 15.16% 3.07% 0.98x 5.06x ILA69.13 Million
2007 1.96% 1.04% 0.22x 8.66x ILA-462.10 Million
2008 19.67% 1.62% 1.35x 9.04x ILA157.30 Million
2009 0.33% 0.05% 1.03x 6.71x ILA-175.10 Million
2010 19.84% 4.80% 0.70x 5.87x ILA235.10 Million
2011 6.13% 1.30% 0.76x 6.23x ILA-95.50 Million
2012 -6.45% -1.27% 0.73x 6.93x ILA-372.40 Million
2013 -36.80% -5.62% 0.70x 9.29x ILA-788.50 Million
2014 9.44% 2.83% 0.43x 7.79x ILA-10.30 Million
2015 45.79% 8.14% 0.50x 11.22x ILA343.90 Million
2016 -14.43% -2.16% 0.51x 12.96x ILA-196.40 Million
2017 13.33% 2.49% 0.52x 10.26x ILA33.70 Million
2018 39.41% 9.88% 0.55x 7.25x ILA409.70 Million
2019 10.19% 3.00% 0.50x 6.86x ILA3.00 Million
2020 -12.33% -3.43% 0.46x 7.90x ILA-313.30 Million
2021 5.72% 1.27% 0.57x 7.97x ILA-65.80 Million
2022 38.80% 9.52% 0.76x 5.33x ILA707.40 Million
2023 9.83% 3.62% 0.58x 4.64x ILA-4.60 Million
2024 6.75% 2.78% 0.55x 4.44x ILA-91.60 Million

Industry Comparison

This section compares Israel Corp's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $181,628,540
  • Average return on equity (ROE) among peers: -3611.67%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Israel Corp (ILCO) ILA6.84 Billion 6.18% 0.96x $1.71 Billion
Kafrit (KAFR) $391.79 Million 16.58% 0.92x $172.04 Million
Nur Ink Innovations Ltd (NURI) $35.80K -21737.67% 0.15x $13.92 Million
Polyram Plastic Industries Ltd (POLP) $399.56 Million 17.73% 0.98x $246.74 Million
Rimoni (RIMO) $181.22 Million 22.77% 0.25x $96.75 Million
Sonovia Ltd (SONO) $-154.55K 0.00% 0.00x $1.48K
Turpaz Industries Ltd (TRPZ) $117.33 Million 10.56% 0.89x $2.18 Billion

About Israel Corp

TA:ILCO Israel Specialty Chemicals
Market Cap
$1.71 Billion
ILA636.62 Billion ILA
Market Cap Rank
#6850 Global
#55 in Israel
Share Price
ILA84070.00
Change (1 day)
-0.37%
52-Week Range
ILA78290.00 - ILA122110.00
All Time High
ILA199053.80
About

Israel Corporation Ltd operates in the specialty minerals and chemical businesses in Europe, Asia, South America, North America, and internationally. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The company offers bromine and bromine-based compounds; potash; magnesia, calcium carbonate, and salt products; pure magnesium and magnesium alloy… Read more